Highland Private Wealth Management Atara Biotherapeutics, Inc. Transaction History

Highland Private Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$19.05 - $41.04 $104,775 - $225,720	-5,500 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$28.4 - $41.74 $156,200 - $229,570	5,500 New	5,500 $219,000
Q4 2018 Feb 12, 2019	SELL	$30.9 - $42.97 $169,950 - $236,335	-5,500 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$35.15 - $51.45 $193,325 - $282,975	5,500 New	5,500 $202,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Highland Private Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Highland Private Wealth Management with notifications on news.